Featured Resources

Introducing: LifeScienceXchange

Patients are counting on your R&D community for the next wave of life-saving medicines.

LifeScienceXchange is the catalyst: a platform for leaders from diverse life science disciplines to connect, learn and collaborate, so that together we bring new treatments to patients faster, sustainably and at scale.

Providing actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format.

It will help you understand trends, benchmark your work, inform strategy and ultimately get your new treatments to patients, faster.

Precision Medicine on LifeScienceXchange provides the events and channels for R&D to unlock human data for precise, patient-centric solutions.

LSX Logo - Better Patient Slogan

Learn faster and put new ideas to work

Market Insights unlock key learnings and actionable ideas from our industry-leading live events. We’ve cut and curated more than 6,000 hours of live recordings into quick-watch cuts, so you can get straight to the moments that matter.

Innovate sooner and benchmark success

Our Technology Showcases give you first sight of the breakthroughs driving our industry. We put you in touch with new developments and vendor success stories, so you can understand the tech, connect with the innovators and benchmark your work against the best

Learn and share ideas with industry leaders

Our Thought Leadership opportunities put you at the heart of the conversations accelerating life sciences R&D today. Hear interviews and presentations with key opinion leaders each month — and join the conversation by putting your questions to them live.

Get the full picture faster

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. Each week we identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture.

Clinical Diagnostics

Paving the Road to Multi Omics Bioinformatics

Our May Omics Series discussion group focused on the current uses and potential of multi-omics bioinformatics.
Single Cell Analysis

Single Cell Proteomics: Advancements and Potential

Our April 2022 Omics Series discussion group focused on the potential and future of single-cell proteomics.
Biomarker Discovery & Development

Spatial Biomarkers & Multiplexed Immunofluorescence in Immuno-Oncology

Yu Liang, Director of Clinical Biomarkers at Compugen, leads a discussion on ‘Spatial Biomarkers & Multiplexed Immunofluorescence in Immuno-Oncology.’
Spatial Analysis

Omics US 2022: The Epicentre of the Spatial Omic Conversation

Showcasing the highlights from NextGen Omics: In-Person 2022. We asked Alex Tamburino, Associate Principal Scientist at Merck about his experience at the event.
Spatial Analysis

Spatial Single Cell Metabolomics | Mass Spectrometry & Microscopy Integration

In Conversation With Theodore Alexandrov, Team Leader, European Molecular Biology Laboratory
Genome Editing

Showcasing Bleeding-Edge Genome Editing Companies: NextGen Omics US

Gábor Balázsi, Henry Laufer Professor of Physical and Quantitative Biology at Stony Brook University, takes us through the most valuable features that NextGen Omics US brought us in 2022.
Clinical Diagnostics

De Novo Variants: Genomic Sequencing and Problem Solving for Future Treatments

In this Commentary article, we investigate the application of new research techniques to inspecting genomic data for the presence of de novo variants - genetic alterations present for the first time in one individual as a result of a variant inherited from a parent. Used in combination with data from the 100,000 Genome Project, these techniques could reduce the time taken for patients to receive a diagnosis for rare genetic diseases.
Biomarker Discovery & Development

What’s Next for Predictive Biomarkers in Immunotherapy?

From maximising immune response with combination biomarkers to conducting diagnostic innovation in immunotherapy prognosis, the future of predictive biomarkers is fast approaching. We speak to senior representatives from industry and academia to find out more.
Biomarker Discovery & Development

Developing a biomarker? Keep these 3 takeaways in mind

Three key take aways when you develop biomarkers: one during biomarker discovery, one during biomarker development and one during biomarker validation.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery